Company intelligence / Profile preview

Fab CBD

Milwaukee, Wisconsin, United States

Ownership: Private
Development stage: Other

Overview

Fab CBD is a premium wellness brand that develops and retails hemp-derived cannabidiol (CBD) products. Established in 2017, the company provides a diverse portfolio including full-spectrum CBD oils, gummies, topical creams, and pet treats. The brand emphasizes product transparency through rigorous third-party laboratory testing and the use of organic, non-GMO hemp sourced from Colorado. In May 2021, Fab CBD was acquired by High Tide Inc., a prominent cannabis retail company, to expand its presence in the US e-commerce and global CBD markets.

Therapeutic areas: PsychiatryImmunologyNeurology
Modalities: Small moleculeCannabinoids
Industry: Food & Nutrition

Beyond the preview

Go deeper on Fab CBD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fab CBD.

Explore the full profile